Search Options Stock News and Analysis from Schaeffer's

Stocks Fall Quickly, Gold Hits Fresh Highs

https://www.schaeffersresearch.com/content/ezines/2020/02/20/stocks-fall-quickly-gold-hits-fresh-highs

2/20/2020 12:00 PM

Stocks are suddenly selling off sharply at midday, with the Dow Jones Industrial Average (DJI) down almost 300 points at last check. The losses are just as deep for the S&P 500 Index (SPX) and Nasd...

FDA Nod Sends CLVS Stock Skyrocketing

https://www.schaeffersresearch.com/content/news/2020/01/15/fda-nod-sends-clvs-stock-skyrocketing

1/15/2020 9:12 AM

The shares of health care name Clovis Oncology Inc (NASDAQ:CLVS) are surging in electronic trading, following news the U.S. Food and Drug Administration (FDA) granted priority review status to its Ru...

Clovis Oncology Call Volume Spikes After Downgrade

https://www.schaeffersresearch.com/content/options/2019/09/24/clovis-oncology-call-volume-spikes-after-downgrade

9/24/2019 2:08 PM

SVB Leerink downgraded Clovis Oncology Inc (NASDAQ:CLVS) stock to "market perform" from "outperform," and slashed its price target by $12 to $10. The analyst in coverage called CLVS' licensing deal w...

2 Drug Stocks Dinged by Goldman Downgrades

https://www.schaeffersresearch.com/content/analysis/2019/05/29/2-drug-stocks-dinged-by-goldman-downgrades

5/29/2019 12:56 PM

This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...

Analysts, Options Traders Swarm Sinking CLVS Stock

https://www.schaeffersresearch.com/content/options/2019/04/15/analysts-options-traders-swarm-sinking-clvs-stock

4/15/2019 12:36 PM

Clovis Oncology Inc (NASDAQ:CLVS) late Friday said it was discontinuing a mid-stage trial of its lead cancer drug, rucaparib, in bladder cancer patients following the recommendation of an independent ...

PEOPLE ALSO SEARCH FOR